Heart Test Laboratories (NASDAQ:HSCS) Issues Earnings Results

Heart Test Laboratories (NASDAQ:HSCS) issued its earnings results on Monday. The company reported ($2.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.30) by $0.03, Zacks reports.

Heart Test Laboratories Trading Up 2.1 %

NASDAQ HSCS traded up $0.08 on Monday, reaching $3.85. The company had a trading volume of 25,193 shares, compared to its average volume of 131,480. The company has a quick ratio of 4.02, a current ratio of 4.49 and a debt-to-equity ratio of 0.08. Heart Test Laboratories has a 52 week low of $2.36 and a 52 week high of $18.50. The stock has a market cap of $3.52 million, a price-to-earnings ratio of -0.17 and a beta of 3.23. The stock’s 50 day moving average is $3.26 and its 200-day moving average is $3.83.

Analyst Ratings Changes

Separately, Ascendiant Capital Markets restated a “buy” rating and issued a $15.00 price objective on shares of Heart Test Laboratories in a report on Monday, September 23rd.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.